DK1011696T3 - Behandling af stress og forbehandling mod stress - Google Patents

Behandling af stress og forbehandling mod stress

Info

Publication number
DK1011696T3
DK1011696T3 DK98943592T DK98943592T DK1011696T3 DK 1011696 T3 DK1011696 T3 DK 1011696T3 DK 98943592 T DK98943592 T DK 98943592T DK 98943592 T DK98943592 T DK 98943592T DK 1011696 T3 DK1011696 T3 DK 1011696T3
Authority
DK
Denmark
Prior art keywords
radiation
ozone
stress
mild heating
oxygen gas
Prior art date
Application number
DK98943592T
Other languages
English (en)
Inventor
Pavel Hamet
Johanne Tremblay
Original Assignee
Vasogen Ireland Ltd
Ct De Rech Du Ct Hospitalier D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2218625 external-priority patent/CA2218625A1/en
Priority claimed from CA 2230836 external-priority patent/CA2230836A1/en
Application filed by Vasogen Ireland Ltd, Ct De Rech Du Ct Hospitalier D filed Critical Vasogen Ireland Ltd
Application granted granted Critical
Publication of DK1011696T3 publication Critical patent/DK1011696T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Heads (AREA)
  • Saccharide Compounds (AREA)
DK98943592T 1997-09-12 1998-09-11 Behandling af stress og forbehandling mod stress DK1011696T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5878297P 1997-09-12 1997-09-12
US5917297P 1997-09-17 1997-09-17
CA 2218625 CA2218625A1 (en) 1997-09-12 1997-10-20 Stress treatment and preconditioning against stress
CA 2230836 CA2230836A1 (en) 1998-02-27 1998-02-27 Inducing resistance to ischemic stresses
PCT/CA1998/000869 WO1999013890A1 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress

Publications (1)

Publication Number Publication Date
DK1011696T3 true DK1011696T3 (da) 2004-03-15

Family

ID=27427399

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98943592T DK1011696T3 (da) 1997-09-12 1998-09-11 Behandling af stress og forbehandling mod stress

Country Status (12)

Country Link
EP (1) EP1011696B1 (da)
JP (1) JP4141636B2 (da)
AT (1) ATE253922T1 (da)
AU (1) AU741181B2 (da)
DE (1) DE69819749T2 (da)
DK (1) DK1011696T3 (da)
EA (1) EA003232B1 (da)
ES (1) ES2210814T3 (da)
IL (3) IL135014A0 (da)
NZ (1) NZ503770A (da)
PT (1) PT1011696E (da)
WO (1) WO1999013890A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045124B1 (en) 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
PT1146885E (pt) * 1999-01-12 2003-10-31 Vasogen Ireland Ltd Pre-condicionamento contra a morte celular
CA2271190A1 (en) * 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
DK1214037T3 (da) * 1999-09-16 2004-08-02 Vasogen Ireland Ltd Apparat til konditionering af pattedyrsblod
ATE309807T1 (de) 1999-09-24 2005-12-15 Vasogen Ireland Ltd Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
JP2005504075A (ja) * 2001-09-18 2005-02-10 バソジェン アイルランド リミテッド アポトーシスを模倣する合成要素または天然要素を用いて外傷からの回復を促進するプロセス

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129630C (en) * 1992-02-07 2003-09-23 Anthony E. Bolton Method of increasing the concentration of nitric oxide in blood
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
JPH08652A (ja) * 1994-06-24 1996-01-09 Oskar:Kk 男性機能回復補助器具
ATE246929T1 (de) * 1995-05-05 2003-08-15 Vasogen Ireland Ltd Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen
JPH09227394A (ja) * 1995-12-22 1997-09-02 Taisho Pharmaceut Co Ltd 経口投与用組成物

Also Published As

Publication number Publication date
ES2210814T3 (es) 2004-07-01
DE69819749D1 (de) 2003-12-18
WO1999013890A1 (en) 1999-03-25
IL135018A0 (en) 2001-05-20
IL135014A0 (en) 2001-05-20
EP1011696B1 (en) 2003-11-12
DE69819749T2 (de) 2004-09-30
EA003232B1 (ru) 2003-02-27
JP4141636B2 (ja) 2008-08-27
EA200000312A1 (ru) 2001-04-23
ATE253922T1 (de) 2003-11-15
JP2001516723A (ja) 2001-10-02
AU741181B2 (en) 2001-11-22
NZ503770A (en) 2002-10-25
PT1011696E (pt) 2004-03-31
HK1031322A1 (en) 2001-06-15
IL135018A (en) 2006-06-11
AU9148098A (en) 1999-04-05
EP1011696A1 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
UY24805A1 (es) Peptidos y compuestos que se enlazan al receptor de la trombopoyetina
MX9300607A (es) Aparato y metodo para tratamiento intersticial.
BR9405763A (pt) Processo para tratar fluido corpóreo processo para tratar produto de sangue e processo para fornecer produtos de sangue a paciente
BG101392A (en) Method of treating diabetes mellitus using kgf
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
NO20013004L (no) Anvendelse av biokjemiske substanser i en sammensetning for forhindringen og behandlingen av helsetilstander forårsaket avkonstriksjon av glattmuskelceller i organer i det menneskeligelegemet
CY1111782T1 (el) Μεθοδος για βιομηχανικη θεραπεια μεσω κυματων
NO891852D0 (no) Fremgangsmaate og middel til sterilisering.
DE69819749D1 (de) Behandlung von stress und vorbehandlng gegen stress
ATE191852T1 (de) Photodynamische konjugate mit biozide eigenschaften
TR28228A (tr) Deri gönlerinin islak muamelesi.
MX9307667A (es) Metodo de tratamiento termico rapido para fibra de polibenzazol.
ES2173464T3 (es) Preparacion de clorinas y bacterioclorinas con contenido en polieter.
BR9608147A (pt) Método para descontaminação microbiana de plaquetas sanguìneas.
ES2046944B1 (es) Procedimiento para la destruccion de microorganismos y enzimas mediante la aplicacion combinada de calor y ultrasonidos bajo presion: proceso mts (mano-termo-sonicacion).
BR9709264A (pt) Processo para produzir e composto
PL1773890T3 (pl) Sposób wytwarzania heparyny niskocząsteczkowej
EA199800821A1 (ru) Способ лечения аутизма
DE69114707D1 (de) Neue alpha-glukosidaseinhibitoren.
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.
ES2173180T3 (es) Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos.
ES2150142T3 (es) Tratamiento biologico de aguas residuales con altas concentraciones de lodos.
AU1275400A (en) Method and apparatus for treating contaminated waste
EA199800818A1 (ru) Способ лечения бессонницы
ES2017609T3 (es) Procedimiento para la destruccion de hipocloritos en una solucion de clorato.